Pepscan continues to supply personalized peptide pools for Evaxion’s upcoming phase IIb trial after successful completion of phase I/IIa 18 March 2022
Pepscan announces research collaboration with Fusion Pharmaceuticals to discover and develop peptide-based radiopharmaceuticals 13 January 2022
Column purification technology expanded to guarantee short timelines and flexibility for (GMP) batches 20 December 2021
PamGene highlights new publications underscoring the importance of its kinome activity profiling technology, the basis of the IOpener® diagnostic test 29 July 2021
Pepscan expands capacity at multiple gram scales to keep delivering optimal flexibility for its (GMP) customers 15 July 2021
Viewpoint Molecular Targeting® Partners with Industry Leader Pepscan to Accelerate Peptide Discovery Program 7 July 2021
